Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Net Income: 2018-2024

Historic Net Income for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to -$56.5 million.

  • Gossamer Bio's Net Income fell 56.55% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.2 million, marking a year-over-year increase of 5.12%. This contributed to the annual value of -$56.5 million for FY2024, which is 68.56% up from last year.
  • According to the latest figures from FY2024, Gossamer Bio's Net Income is -$56.5 million, which was up 68.56% from -$179.8 million recorded in FY2023.
  • Gossamer Bio's 5-year Net Income high stood at -$56.5 million for FY2024, and its period low was -$243.2 million during FY2020.
  • Over the past 3 years, Gossamer Bio's median Net Income value was -$179.8 million (recorded in 2023), while the average stood at -$155.2 million.
  • Its Net Income has fluctuated over the past 5 years, first crashed by 33.24% in 2020, then spiked by 68.56% in 2024.
  • Over the past 5 years, Gossamer Bio's Net Income (Yearly) stood at -$243.2 million in 2020, then increased by 3.45% to -$234.8 million in 2021, then grew by 2.31% to -$229.4 million in 2022, then increased by 21.61% to -$179.8 million in 2023, then skyrocketed by 68.56% to -$56.5 million in 2024.